Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02498899 · ClinicalTrials.gov registry record · NA

Message 2: The Effect of Message Content and Clinical Outcome on Patient's Perception of Physician Compassion

A NA study, sponsored by M.D. Anderson Cancer Center.

Completed
Registry status
NA
Development phase
148
Enrollment target

NCT02498899: Completed NA study, sponsored by M.D. Anderson Cancer Center.

NCT02498899 is a NA study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 148 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02498899, a NA study, has completed, sponsored by M.D. Anderson Cancer Center.

COMPLETED
Registry status
NA
Development phase
148 participants
Enrollment target

Study Summary

The goal of this research study is to learn how patients view their doctor's compassion about supportive care and treatment options for advanced cancer patients.

Primary Outcome

Participant's rating of physician's compassion scored by using a 5-item tool consisting of five 0-10 numerical rating scales assessing five dimensions: warm-cold, pleasant-unpleasant, compassionate-distant, sensitive insensitive, caring-uncaring. Sum of the five scales gives a final score representing physician's compassion with a 0 to 50 scale.

Interventions

  • BEHAVIORAL Questionnaires
  • BEHAVIORAL Video

Trial Details

FieldValue
Enrollment Target 148 participants
Start Date 2015-07
Est. Completion 2018-12-06
Phase NA
M.D. Anderson Cancer Center

2,692 total trials

What the finished NCT02498899 record still lists

NCT02498899 is an interventional study that assigns participants to a tested intervention. The registered 148 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).

The record links to 0 conditions, and to 2 interventions - of which Questionnaires is the first listed.

NCT02498899 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02498899 about?

NCT02498899 is a clinical study titled "Message 2: The Effect of Message Content and Clinical Outcome on Patient's Perception of Physician Compassion". The goal of this research study is to learn how patients view their doctor's compassion about supportive care and treatment options for advanced cancer patients.

What is the current status of trial NCT02498899?

This trial is currently completed. It is a NA study. The enrollment target is 148 participants. The study started on 2015-07. Estimated completion is 2018-12-06.

What interventions are being tested in trial NCT02498899?

The interventions under investigation include: Questionnaires (BEHAVIORAL), Video (BEHAVIORAL).

Who is sponsoring clinical trial NCT02498899?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02498899's enrollment target sits among peer trials

148 702nd of 2000 higher than 1,298 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00739362 · 148 participants · Phase 2

    Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment

  • NCT03161223 · 148 participants · Phase 1

    Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma

  • NCT03858231 · 148 participants · Phase 4

    Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery

  • NCT04486352 · 148 participants · Phase 1

    A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02498899, the US trial registry maintained by the National Library of Medicine. NCT02498899 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.